name: AVOBENZONE 2.5 g in 100 g / OCTISALATE 2.15 g in 100 g / HOMOSALATE 3.5 g in 100 g / OCTOCRYLENE 5.0 g in 100 g TOPICAL STICK [Refreshing Water Hydration Stick SPF 50]


name: ZINC OXIDE 13.63 g in 100 g TOPICAL STICK [Mineral Sunscreen Stick SPF 50 Fragrance-Free]


name: ANACAULASE-BCDB 158 mg in 1 g TOPICAL POWDER [NEXOBRID]


name: GLYCERIN 0.555 g in 30 mL / PHENOXYETHANOL 0.243 g in 30 mL / XANTHAN GUM 0.09 g in 30 mL / FRAGRANCE 13576 0.027 g in 30 mL / SORBITAN ISOSTEARATE 0.024 g in 30 mL / HYDROLYZED BOVINE ELASTIN (BASE; 1000 MW) 0.0012 g in 30 mL / LIMONENE, (+)- 0.0009 g in 30 mL / TOCOPHEROL 0.0003 g in 30 mL / HYDROXYCITRONELLAL 0.0006 g in 30 mL / LECITHIN, SOYBEAN 0.45 g in 30 mL / HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (100000 MPA.S AT 1.5%) 0.405 g in 30 mL / DEHYDROACETIC ACID 0.021 g in 30 mL / PROPANEDIOL 1.08 g in 30 mL / DICAPRYLYL ETHER 0.9 g in 30 mL / BENZOIC ACID 0.036 g in 30 mL / ASCORBYL GLUCOSIDE 0.15 g in 30 mL / WATER 25.5564 mL in 30 mL / POLYSORBATE 60 0.024 g in 30 mL TOPICAL CONCENTRATE [Anubis Barcelona]


name: ZINC OXIDE 17.9 g in 100 g TOPICAL STICK [Bare Republic Mineral SPF 50]


name: OCTOCRYLENE 9.5 g in 100 mL / AVOBENZONE 2.8 g in 100 mL / HOMOSALATE 9.8 g in 100 mL / OCTISALATE 4.9 g in 100 mL TOPICAL LOTION [Vacation SPF 50 Classic]


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Emzahh 28 Day]


name: HOMOSALATE 8.8 g in 100 mL / AVOBENZONE 2.9 g in 100 mL / OCTOCRYLENE 8.6 g in 100 mL / OCTISALATE 4.9 g in 100 mL TOPICAL SPRAY [Vacation SPF 50 Classic]


name: Leucine 0.0025 g in 5 mL / Isoleucine 0.0025 g in 5 mL TOPICAL LIQUID [ExoSCRT Derma Signal SRLV Vial 2. Diluent]


name: ZINC OXIDE 17 g in 100 g TOPICAL LOTION [LESS EVERY TONE SPF 30]


name: ZINC OXIDE 94 mg in 1 mL TOPICAL CREAM [Curology Everyday Sunscreen Broad Spectrum SPF 30 No-clog UV defense]


name: HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / ZINC OXIDE 70 mg in 1 mL TOPICAL CREAM [Face Cream 50]


name: Zinc Oxide 10.5 g in 100 g TOPICAL STICK [Norwex Natural Sunscreen Lip Balm Broad Spectrum SPF 15]


name: Zinc Oxide 20 g in 100 g TOPICAL OINTMENT [Norwex Natural Sunscreen Broad Spectrum SPF 30]


name: Aluminum Sesquichlorohydrate 0.15 kg in 1 kg TOPICAL Lotion [Carpe Antiperspirant Underarm Coconut Vanilla Scent]


name: TITANIUM DIOXIDE 7.75 g in 100 mL / ZINC OXIDE 10 g in 100 mL TOPICAL CREAM [Smooth Even Glow Tinted Mineral Sunscreen Broad Spectrum SPF30]


name: ZINC OXIDE 0.21 g in 1 g / TITANIUM DIOXIDE 0.06 g in 1 g TOPICAL POWDER [Brush on Block Mineral Powder Sunscreen Translucent]


name: ZINC OXIDE 20.5 g in 100 g TOPICAL LOTION [TRADER JOES ZINC OXIDE SUNSCREEN SPF 40]


name: GUANABENZ ACETATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 14 g in 100 mL TOPICAL LOTION [Rose Inc. Solar Power Luminous Serum SPF30]


name: TITANIUM DIOXIDE 5.76 g in 100 g / ZINC OXIDE 2.94 g in 100 g TOPICAL CREAM [Super CC Color Correction Care Cream]


name: diphenhydramine / hydrocortisone / pramoxine


name: HOMOSALATE 9.8 mg in 100 mL / OCTISALATE 4.9 mg in 100 mL / AVOBENZONE 2.9 mg in 100 mL / OCTOCRYLENE 9.5 mg in 100 mL TOPICAL SPRAY [Glow Baby Brightening Setting Mist SPF 45]


name: TITANIUM DIOXIDE 7.75 g in 100 mL / ZINC OXIDE 10 g in 100 mL TOPICAL CREAM [Antioxidant Tinted Mineral Sunscreen Broad Spectrum SPF30]


name: ZINC OXIDE 10 g in 100 g TOPICAL STICK [Attitude Oceanly Phyto-Sun Tinted - SPF 15 - Broad Spectrum Sunscreen]


name: ZINC OXIDE 14.5 g in 100 mL TOPICAL LIQUID [Sun Plus Skincare SPF 30 Mineral Bronzing Sunscreen Coconut Glow]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OXYBENZONE 60 mg in 1 g TOPICAL SPRAY [CVS Health Sport SPF 70 Clear]


name: ISOFLUPREDONE ACETATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: Idoxuridine 1 kg in 1 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 16 g in 100 mg TOPICAL CREAM [Sun Plus Skincare SPF 30 Mineral Face Shade Coconut Probiotic]


name: ATIPAMEZOLE HYDROCHLORIDE 1 kg in 1 kg NOT APPLICABLE POWDER


name: Healthcare Common Procedure Coding System, 2023


name: HCPCS Version of Current Procedural Terminology (CPT), 2023


name: Skin substitute, fda cleared as a device, not otherwise specified


name: Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service


name: Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service


name: Cranial electrotherapy stimulation (ces) system supplies and accessories, per month


name: Prescription digital cognitive and/or behavioral therapy, fda cleared, per course of treatment


name: Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination device (insertable)


name: Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging system


name: Generator, neurostimulator (implantable), non-rechargeable, with implantable stimulation lead and external paired stimulation controller


name: Pressure sensor system, includes all components (e.g., introducer, sensor), intramuscular (implantable), excludes mobile (wireless) software application


name: Debridement, bone including epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed, first 20 sq cm or less with manual preparation and insertion of deep (eg, subfacial) drug-delivery device(s)


name: Percutaneous breast biopsies using stereotactic guidance, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral and bilateral (for single lesion biopsy, use appropriate code)


name: Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code)


name: Open biopsy or excision of deep cervical node(s) with intraoperative identification (eg, mapping) of sentinel lymph node(s) including injection of non-radioactive dye when performed


name: Percutaneous vertebroplasties (bone biopsies included when performed), first cervicothoracic and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance


name: Percutaneous vertebroplasties (bone biopsies included when performed), first lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance


name: Percutaneous vertebral augmentations, first thoracic and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (eg, kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance


name: Percutaneous vertebral augmentations, first lumbar and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (eg, kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance


name: Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when performed, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed


name: Bronchoscopy, rigid or flexible, with bronchial alveolar lavage(s), with computer-assisted image-guided navigation, including fluoroscopic guidance when performed


name: Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed


name: Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance when performed


name: Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty of central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report


name: Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with all angioplasty in the central dialysis segment, and transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report


name: Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with dialysis circuit permanent endovascular embolization or occlusion of main circuit or any accessory veins, including all required imaging, radiological supervision and interpretation, image documentation and report


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging, supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) includes intraprocedural injection(s) for bypass graft angiography with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right heart catheterization, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty and all angioplasty in the central dialysis segment, with transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging, radiological supervision and interpretation, documentation and report


name: Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal angioplasty with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation


name: Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation


name: Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy


name: Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with atherectomy, includes angioplasty within the same vessel, when performed with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation


name: Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal stent placement(s), includes angioplasty within the same vessel, when performed, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation


name: Insertion of new or replacement of permanent pacemaker with atrial transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable debribrillator or pacemake pulse generator (eg, for upgrade to dual chamber system)


name: Insertion of new or replacement of permanent pacemaker with ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defribrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)


name: Insertion of new or replacement of permanent pacemaker with atrial and ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)


name: Removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator, dual lead system, with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)


name: Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including collection of specimen(s) by brushing or washing, when performed, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)


name: Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or multiple, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)


name: Endoscopic retrograde cholangiopancreatography (ercp) with sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)


name: Endoscopic retrograde cholangiopancreatography (ercp) with removal of calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)


name: Percutaneous exchange of biliary drainage catheter (eg, external, internal-external, or conversion of internal-external to external only), with removal of calculi/debris from biliary duct(s) and/or gallbladder, including destruction of calculi by any method (eg, mechanical, electrohydraulic, lithotripsy) when performed, including diagnostic cholangiography(ies) when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation


name: Removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, with ureteral stricture balloon dilation, including imaging guidance and all associated radiological supervision and interpretation


name: Convert nephrostomy catheter to nephroureteral catheter, percutaneous via pre-existing nephrostomy tract, with ureteral stricture balloon dialation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation


name: Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation


name: Change of ureterostomy tube or externally accessible ureteral stent via ileal conduit with ureteral stricture balloon dilation, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation


name: Cystourethroscopy, with biopsy(ies) with adjuctive blue light cystoscopy with fluorescent imaging agent


name: Excision of major peripheral nerve neuroma, except sciatic, with implantation of nerve end into bone or muscle


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress, initial vessel


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed


name: Cystourethroscopy with adjunctive blue light cystoscopy with fluorescent imaging agent


name: Thyroidectomy, total or complete with parathyroid autotransplantation


name: Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, initial 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service


name: Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, initial 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service


name: Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)


name: Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed


name: Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study


name: Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catherization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study


name: Adjunctive, non-implanted continuous glucose monitor or receiver


name: Non-adjunctive, non-implanted continuous glucose monitor or receiver


name: Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service, 5 to 15 mins time (this code is used for medicaid billing purposes)


name: Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service, 16-30 mins time (this code is used for medicaid billing purposes)


name: Immunization counseling by a physician or other qualify ed health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes)


name: Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 16-30 mins time (this code is used for medicaid billing purposes)


name: Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 16-30 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)


name: Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)


name: Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99223, 99233, and 99236 for hospital inpatient or observation care evaluation and management services). (do not report g0316 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418, 99415, 99416). (do not report g0316 for any time unit less than 15 minutes)


name: Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99306, 99310 for nursing facility evaluation and management services). (do not report g0317 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418). (do not report g0317 for any time unit less than 15 minutes)


name: Prolonged home or residence evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99345, 99350 for home or residence evaluation and management services). (do not report g0318 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99417). (do not report g0318 for any time unit less than 15 minutes)


name: Home health services furnished using synchronous telemedicine rendered via a real-time two-way audio and video telecommunications system


name: Home health services furnished using synchronous telemedicine rendered via telephone or other real-time interactive audio-only telecommunications system


name: The collection of physiologic data digitally stored and/or transmitted by the patient to the home health agency (i.e., remote patient monitoring)


name: Care management services for behavioral health conditions, at least 20 minutes of clinical psychologist or clinical social worker time, per calendar month. (these services include the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, coordination with and/or referral to physicians and practitioners who are authorized by medicare to prescribe medications and furnish e/m services, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team)


name: Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room


name: Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.)


name: Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.)


name: Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis


name: Skills training and development, per diem


name: Cranial electrotherapy stimulation (ces) system, any type


name: Replacement supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wrist


name: Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle for the reduction of snoring and obstructive sleep apnea, controlled by phone application


name: Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply


name: External recharging system for battery (internal) for use with implanted cardiac contractility modulation generator, replacement only


name: Non-pneumatic compression controller without calibrated gradient pressure


name: Non-pneumatic sequential compression garment, full leg


name: Non-pneumatic sequential compression garment, half leg


name: Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count


name: Advancing cancer care mips value pathways


name: Optimal care for kidney health mips value pathways


name: Optimal care for patients with episodic neurological conditions mips value pathways


name: Supportive care for neurodegenerative conditions mips value pathways


name: Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring


name: Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency


name: Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency


name: Human health factor 10 amniotic patch (hhf10-p), per square centimeter


name: Celera dual layer or celera dual membrane, per square centimeter


name: Dual layer impax membrane, per square centimeter


name: Counseling, individual, by chaplain services


name: Services performed by a doula birth worker, per 15 minutes


name: Services performed by a doula birth worker, per diem


name: Financial management, self-directed, waiver; per diem


name: Supports brokerage, self-directed, waiver; per diem


name: Contact lens, hydrophilic, dual focus, per lens


name: Audiology service furnished personally by an audiologist without a physician/npp order for non-acute hearing assessment unrelated to disequilibrium, or hearing aids, or examinations for the purpose of prescribing, fitting, or changing hearing aids; service may be performed once every 12 months, per beneficiary


name: Temporary Codes Assigned to DME Regional Carriers - Self-administered test


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (sarscov-2) (coronavirus disease [covid-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 ml dosage; booster dose


name: Oncology (oropharyngeal), evaluation of 17 dna biomarkers using droplet digital pcr (ddpcr), cell-free dna, algorithm reported as a prognostic risk score for cancer recurrence


name: Oncology (melanoma), artificial intelligence (ai)-enabled quantitative mass spectrometry analysis of 142 unique pairs of glycopeptide and product fragments, plasma, prognostic, and predictive algorithm reported as likely, unlikely, or uncertain benefit from immunotherapy agents


name: Neurology (mild cognitive impairment), analysis of b-amyloid 1-42 and 1-40, chemiluminescence enzyme immunoassay, cerebral spinal fluid, reported as positive, likely positive, or negative


name: Oncology (prostate cancer), analysis of all prostate-specific antigen (psa) structural isoforms by phase separation and immunoassay, plasma, algorithm reports risk of cancer


name: Oncology (lung), enzyme-linked immunosorbent assay (elisa) of 7 autoantibodies (p53, ny-eso-1, cage, gbu4-5, sox2, mage a4, and hud), plasma, algorithm reported as a categorical result for risk of malignancy


name: Neurofilament light chain, digital immunoassay, plasma, quantitative


name: Oncology (papillary thyroid cancer), gene-expression profiling via targeted hybrid capture-enrichment rna sequencing of 82 content genes and 10 housekeeping genes, formalin-fixed paraffin embedded (ffpe) tissue, algorithm reported as one of three molecular subtypes


name: Oncology (urothelial), mrna, geneexpression profiling by real-time quantitative pcr of 5 genes (mdk, hoxa13, cdc2 [cdk1], igfbp5, and cxcr2), utilizing urine, algorithm incorporates age, sex, smoking history, and macrohematuria frequency, reported as a risk score for having urothelial carcinoma


name: Medical Dictionary for Regulatory Activities Terminology (MedDRA), Arabic Edition


name: Biloxi-Chitimacha Confederation of Muskogee


name: Edisto Natchez Kusso Tribe of South Carolina


name: Pribilof Islands Aleut Communities of St. Paul and St. George Islands


name: San Manuel Band of Mission Indians, California


name: Te-Moak Tribe of Western Shoshone Indians of Nevada


name: abacavir, lamivudine, and zidovudine drug combination


name: Diversity, Equity, Inclusion, and Belonging


name: Diversity, Equality, Inclusion, and Accessibility


name: Death Valley Timbisha Shoshone Band of California


name: Arapaho Tribe of the Wind River Reservation, Wyoming


name: Native Village of Venetie Tribal Government


name: Burt Lake Band of Ottawa and Chippewa Indians


name: Lumbee TribeLumbee Tribe of North Carolina


name: Ma-Chis Lower Creek Indian Tribe of Alabama


name: Mackinac Bands of Chippewa and Ottawa Indians


name: Bayou Lafourche Band of Biloxi-Chitimacha Confederation of Muskogees


name: Nulhegan Band of the Coosuk Abenaki Nation


name: Paucatuck Eastern Pequot Indians of Connecticut


name: Pee Dee Indian Nation of Upper South Carolina


name: Piscataway Indian Nation and Tayac Territory


name: Swan Creek Black River Confederated Ojibwa Tribes of Michigan


name: Ute Mountain Tribe of the Ute Mountain Reservation, Colorado, New Mexico and Utah


name: Prenatal visits for this pregnancy:Find:Pt:^Patient:Ord


name: Cardiac device monitoring report:Find:Pt:Heart:Doc


name: MDS v3.0 - RAI v1.18.11 - Self-Care - Discharge Goal:-:RptPeriod:^Patient:-:CMS Assessment


name: Health informatics leader and champion of semantic interoperability


name: Health informatics leader and champion of semantic interoperability:Hx:Pt:^Patient:Nar


name: Semen & urine analysis fertility panel:-:Pt:XXX:-


name: Portable medical order completion information


name: Portable medical order completion information:-:-:^Patient:-:POLST


name: MDS v3.0 - RAI v1.18.11 - Self-Care - Admission Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Health informatics pioneer and cofounder of LOINC


name: Health informatics pioneer and cofounder of LOINC:Hx:Pt:^Patient:Nar


name: Change in mental status:Find:Pt:^Patient:Ord


name: MDS v3.0 - RAI v1.18.11 - Self-Care - Admission Performance


name: CD49d cell expression evaluation:Find:Pt:XXX:Doc:Flow cytometry


name: CD20 cell expression evaluation:Find:Pt:XXX:Doc:Flow cytometry


name: Organ &or tissue donation consent:Find:Pt:{Setting}:Doc:Patient


name: Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]


name: Aryl Hydrocarbon Receptor Agonists [MoA]


name: destruction of nasal turbinate (treatment)


name: occlusion of inferior vena cava (treatment)


name: occlusion of superior vena cava (treatment)


name: MDS v3.0 - RAI v1.18.11 - Mobility - Discharge Goal


name: Chief technical architect and steadfast leader of LOINC


name: Chief technical architect and steadfast leader of LOINC:Hx:Pt:^Patient:Nar


name: MDS v3.0 - RAI v1.18.11 - Self-Care - Discharge Goal


name: Health informatics pioneer and the father of LOINC


name: Health informatics pioneer and the father of LOINC:Hx:Pt:^Patient:Nar


name: CHAMPS pediatric fall risk assessment:-:Pt:^Patient:-:CHAMPS


name: Schmid fall risk assessment:-:Pt:^Patient:-:Schmid


name: MMP1, 1-BP INS, -1607G, PROMOTER (dbSNP rs1799750)


name: DGAT1, 3-BP DEL, 629CCT (dbSNP rs782577883)


name: OBSCN, IVS24DS, G-T, +1 (dbSNP rs200849058)


name: HSD17B13, IVS6DS, 1-BP INS, A (dbSNP rs72613567)


name: TANGO2, 34-KB DEL, EX3-9DEL (dbSNP SCV000245443)


name: International Classification for Nursing Practice, 2022


name: Pathology report.additional specified observation:Find:Pt:Specimen:Nar


name: Pathology report.additional specified observation


name: Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel:-:Pt:Nose:-:Non-probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Nose:Ord:Non-probe.amp.tar


name: Influenza virus B RNA:PrThr:Pt:Nose:Ord:Non-probe.amp.tar


name: JC virus Ab Index:ACnc:Pt:Ser/Plas:Qn:IA


name: Varicella Zoster Virus DNA:LnCnc:Pt:XXX:Qn:Probe.amp.tar


name: HIV reverse transcriptase failed codons:Prid:Pt:Isolate:Nom:Genotyping


name: HIV 1 group M RNA genotype:Prid:Pt:Isolate:Nom:Genotyping


name: HIV protease failed codons:Prid:Pt:Isolate:Nom:Genotyping


name: HIV integrase failed codons:Prid:Pt:Isolate:Nom:Genotyping


name: Lymphocyte T-cell & B-cell & Natural killer subsets panel:-:Pt:CSF:-


name: Blood group antigens panel:-:Pt:RBC^Father:-


name: CD52 cell expression evaluation:Find:Pt:XXX:Doc:Flow cytometry


name: B-cell CD19 & CD20 subsets panel:-:Pt:Bld:-:Flow cytometry


name: Respiratory Allergen Panel, Area 5:-:Pt:Ser:-


name: Cortisol post dose insulin IV panel:-:Pt:Ser/Plas:-


name: Somatotropin post dose insulin IV panel:-:Pt:Ser/Plas:-


name: Monkeypox virus sequencing panel:-:Pt:XXX:-:Sequencing


name: Discharge summary note:Find:Pt:{Setting}:Doc:Osteopathic medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Medical aid in dying


name: History and physical note:Find:Pt:{Setting}:Doc:Integrative medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Bariatric surgery


name: History and physical note:Find:Pt:{Setting}:Doc:Chiropody


name: History and physical note:Find:Pt:{Setting}:Doc:Chiropractic medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Community health care


name: History and physical note:Find:Pt:{Setting}:Doc:Clinical cardiac electrophysiology


name: History and physical note:Find:Pt:{Setting}:Doc:Surgical oncology


name: History and physical note:Find:Pt:{Setting}:Doc:Undersea and hyperbaric medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Kinesiotherapy


name: History and physical note:Find:Pt:{Setting}:Doc:Hospitalist


name: History and physical note:Find:Pt:{Setting}:Doc:Nuclear medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Diabetology


name: History and physical note:Find:Pt:{Setting}:Doc:Optometry


name: History and physical note:Find:Pt:{Setting}:Doc:Osteopathic medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Orthotics prosthetics


name: History and physical note:Find:Pt:{Setting}:Doc:Reproductive endocrinology and infertility


name: History and physical note:Find:Pt:{Setting}:Doc:Sports medicine


name: History and physical note:Find:Pt:Urgent care center:Doc:{Role}


name: History and physical note:Find:Pt:{Setting}:Doc:Child and adolescent psychology


name: History and physical note:Find:Pt:{Setting}:Doc:Cardiac surgery


name: History and physical note:Find:Pt:{Setting}:Doc:Hematology+Medical oncology


name: History and physical note:Find:Pt:{Setting}:Doc:Neuropsychology


name: Progress note:Find:Pt:Urgent care center:Doc:{Role}


name: Consultation note:Find:Pt:Urgent care center:Doc:{Role}


name: Consultation note:Find:Pt:{Setting}:Doc:Undersea and hyperbaric medicine


name: Surgical operation note:Find:Pt:{Setting}:Doc:Bariatric surgery


name: Surgical operation note:Find:Pt:{Setting}:Doc:Reproductive endocrinology and infertility


name: Conference note:Find:Pt:{Setting}:Doc:Critical care medicine.team


name: Conference note:Find:Pt:{Setting}:Doc:Rapid response team


name: A little n super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: B little e super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: C little r super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: C little s super little b Ab:PrThr:Pt:Ser/Plas:Ord


name: C little s super little b Ag:PrThr:Pt:RBC:Ord


name: D little h super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: D little r super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: E little n super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: E little s super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: H little r super little s Ab:PrThr:Pt:Ser/Plas:Ord


name: H little r super B Ab:PrThr:Pt:Ser/Plas:Ord


name: H little u little t Ab:PrThr:Pt:Ser/Plas:Ord


name: I little n super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: J little o super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11:-:Pt:^Patient:-:CMS Assessment


name: Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11


name: MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set


name: National Council of State Boards of Nursing ID:ID:Pt:Provider:Nom


name: National Council of State Boards of Nursing ID


name: Thrombospondin type I domain-containing 7A Ag:PrThr:Pt:Tiss:Ord:IF


name: Sezary syndrome monitoring:Find:Pt:Bld:Doc:Flow cytometry


name: Sezary syndrome diagnosis:Find:Pt:Bld:Doc:Flow cytometry


name: Leukemia and lymphoma immunophenotyping:Find:Pt:XXX:Doc:Flow cytometry


name: Bacterial carbapenem resistance blaIMI gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaIMI+blaNMC genes:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaOXA-235-like gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaOXA-24+blaOXA-40 genes:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaSIM gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Theoretical limit of detection:Num:Pt:XXX:Qn:Calculated


name: Mast cells/100 cells:NFr:Pt:Bone mar:Qn:Flow cytometry


name: B-cell precursors:NFr:Pt:Bone marrow:Qn:Flow cytometry


name: Glucose post XXX challenge panel:-:Pt:Ser/Plas:-


name: End of treatment letter:Find:Pt:{Setting}:Doc:Radiation oncology


name: ER super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: NAT2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: NAT2 gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen


name: NAT2 gene product metabolic activity interpretation


name: Ustekinumab & Ustekinumab Ab panel:-:Pt:Ser/Plas:-


name: Ustekinumab & Ustekinumab Antibody panel


name: Monocyte subsets panel:-:Pt:Bld:-:Flow cytometry


name: Borrelia burgdorferi Ab.IgM index:ACnc:Pt:Ser+CSF:Qn


name: Mitochondria whole genome analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Chemokine (C-C motif) ligand 14:MCnc:Pt:Urine:Qn:IA


name: Soluble urokinase plasminogen activator receptor:MCnc:Pt:Ser/Plas:Qn


name: Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis rRNA panel:-:Pt:XXX:-:Probe.amp.tar


name: Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis rRNA panel


name: Pneumocystis jiroveci DNA:ThreshNum:Pt:Respiratory System Specimen:Qn:Probe.amp.tar


name: Sphincter excision plane:Anat:Pt:Colorectal cancer specimen:Nom


name: Mesocolic excision plane:Anat:Pt:Colorectal cancer specimen:Nom


name: Depth of invasion beyond muscularis propria:Len:Pt:Colorectal cancer specimen:Qn


name: Depth of invasion beyond muscularis propria


name: Inflammatory cell infiltrate:Find:Pt:Colorectal cancer specimen:Nom


name: Lymph nodes with metastasis/Lymph nodes examined:NFr:Pt:Colorectal cancer specimen:Qn


name: Lymph nodes with metastasis/Lymph nodes examined


name: Measles virus Ab.IgG index:ACnc:Pt:Ser+CSF:Qn


name: Mumps virus Ab.IgG index:ACnc:Pt:Ser+CSF:Qn


name: Herpes simplex virus 1+2 Ab.IgG index:ACnc:Pt:Ser+CSF:Qn


name: Varicella zoster virus Ab.IgA:ACnc:Pt:Ser/Plas:Qn:IA


name: Dengue virus NS1 Ag:ACnc:Pt:Ser/Plas:Qn:IA


name: Hepatitis E virus Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hepatitis E virus Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus Ab.IgG panel:-:Pt:Ser/Plas:-:Line blot


name: Hantavirus puumala Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus sin nombre Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus hantaan Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus Ab.IgM panel:-:Pt:Ser/Plas:-:Line blot


name: Hantavirus puumala Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus sin nombre Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus hantaan Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus dobrava Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: SUMO-activating enzyme subunit 1 Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: PM-SCL-100 extractable nuclear Ab:ACnc:Pt:Ser:Qn:IA


name: PKD1 gene & PKD2 gene deletion+duplication:Find:Pt:Bld/Tiss:Doc:MLPA


name: Hemosiderin:PrThr:Pt:Bld/Bone mar:Ord:Prussian blue stain


name: Purkinje cell cytoplasmic type Tr Ab:PrThr:Pt:CSF:Ord:IB


name: Zinc finger protein of the cerebellum 4 Ab:PrThr:Pt:Ser:Ord:IB


name: Zinc finger protein of the cerebellum 4 Ab:PrThr:Pt:CSF:Ord:IB


name: Glutamate decarboxylase 65 Ab:PrThr:Pt:CSF:Ord:IB


name: Glutamate decarboxylase 65 Ab:PrThr:Pt:Ser:Ord:IB


name: Glial nuclear type 1 Ab:PrThr:Pt:CSF:Ord:IB


name: Glial nuclear type 1 Ab:PrThr:Pt:Ser:Ord:IB


name: Mean chromosome banding resolution:Num:Pt:Bld/Tiss:Qn:Banding


name: Contactin-associated protein 2 Ab:PrThr:Pt:Ser/Plas:Ord:IF


name: Contactin-associated protein 2 Ab:PrThr:Pt:CSF:Ord:IF


name: Dipeptidyl aminopeptidase-like protein 6 Ab:PrThr:Pt:CSF:Ord:IF


name: Dipeptidyl aminopeptidase-like protein 6 Ab:PrThr:Pt:Ser/Plas:Ord:IF


name: Leucine-rich glioma-inactivated protein 1 Ab:PrThr:Pt:CSF:Ord:IF


name: Leucine-rich glioma-inactivated protein 1 Ab:PrThr:Pt:Ser/Plas:Ord:IF


name: Dense fine speckled 70 protein Ab:PrThr:Pt:Ser/Plas:Ord


name: Herpes virus 6 DNA:ACnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:ACnc:Pt:Bld:Qn:Probe.amp.tar


name: Silica clotting time.excess phospholipid actual/Normal:RelTime:Pt:PPP:Qn


name: Silica clotting time.excess phospholipid actual/Normal


name: MDS v3.0 - RAI v1.18.11 - Identification Information:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Identification Information


name: MDS v3.0 - RAI v1.18.11 - Hearing, Speech, and Vision:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Hearing, Speech, and Vision


name: MDS v3.0 - RAI v1.18.11 - Cognitive Patterns:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Cognitive Patterns


name: MDS v3.0 - RAI v1.18.11 - Mood:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Behavior:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Preferences for Customary Routine and Activities:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Preferences for Customary Routine and Activities


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Admission:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Discharge:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Discharge


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - OBRA &or Interim:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - OBRA &or Interim


name: MDS v3.0 - RAI v1.18.11 - Bladder and Bowel:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Bladder and Bowel


name: MDS v3.0 - RAI v1.18.11 - Active Diagnoses:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Active Diagnoses


name: MDS v3.0 - RAI v1.18.11 - Health Conditions:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Health Conditions


name: MDS v3.0 - RAI v1.18.11 - Swallowing &or Nutritional Status:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Swallowing &or Nutritional Status


name: MDS v3.0 - RAI v1.18.11 - Oral &or Dental Status:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Oral &or Dental Status


name: MDS v3.0 - RAI v1.18.11 - Skin Conditions:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Skin Conditions


name: MDS v3.0 - RAI v1.18.11 - Medications:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Header - Special Treatments, Procedures, and Programs:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Header - Special Treatments, Procedures, and Programs


name: MDS v3.0 - RAI v1.18.11 - Restraints and Alarms:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Restraints and Alarms


name: MDS v3.0 - RAI v1.18.11 - Participation in Assessment and Goal Setting:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Participation in Assessment and Goal Setting


name: MDS v3.0 - RAI v1.18.11 - Care Area Assessment (CAA) Summary:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Care Area Assessment (CAA) Summary


name: MDS v3.0 - RAI v1.18.11 - Correction Request:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Correction Request


name: MDS v3.0 - RAI v1.18.11 - Assessment Administration:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Assessment Administration


name: Pharyngeal pathogens DNA & RNA panel:-:Pt:Thrt:-:Non-probe.amp.tar


name: Human coronavirus 229E+HKU1+NL63+OC43 RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: SARS coronavirus 2 RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Influenza virus A H1 2009 pandemic RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Influenza virus A H3 RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Influenza virus B RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Parainfluenza virus 1+2+3+4 RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Respiratory syncytial virus RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Streptococcus dysgalactiae subspecies equisimilis DNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Views 2 && Views AP + lateral:Find:Pt:Chest>Spine.thoracic && Abdomen:Doc:XR


name: Dengue virus 1+2+3+4 RNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Glucose post arginine stimulation panel:-:Pt:Ser/Plas:-


name: Glucose^2H post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin post insulin stimulation panel:-:Pt:Ser/Plas:-


name: Somatotropin post insulin stimulation panel


name: 17-Hydroxyprogesterone^30M post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^1H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone post corticotropin stimulation panel:-:Pt:Ser/Plas:-


name: 17-Hydroxyprogesterone post corticotropin stimulation panel


name: 17-Hydroxypregnenolone & 17-Hydroxyprogesterone post corticotropin stimulation panel:-:Pt:Ser/Plas:-


name: 17-Hydroxypregnenolone & 17-Hydroxyprogesterone post corticotropin stimulation panel


name: Cortisol & 17-Hydroxyprogesterone post corticotropin stimulation panel:-:Pt:Ser/Plas:-


name: Cortisol & 17-Hydroxyprogesterone post corticotropin stimulation panel


name: 17-Hydroxypregnenolone^30M post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^1H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Cortisol & Cortisone panel:-:24H:Urine:-


name: MDS v3.0 - RAI v1.18.11 - Mobility - Admission Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Mobility - Admission Performance


name: MDS v3.0 - RAI v1.18.11 - Mobility - Discharge Goal:-:RptPeriod:^Patient:-:CMS Assessment


name: Tub &or shower transfer - functional goal:Find:Pt:^Patient:Ord:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Pain assessment interview:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Pain assessment interview


name: Nutritional approaches - on admission:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Nutritional approaches - at discharge:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Participation in assessment and goal setting:-:Pt:^Patient:-:CMS Assessment


name: Number of venous and arterial ulcers:Num:RptPeriod:^Patient:Qn:CMS Assessment


name: Ulcers, wounds and skin problems:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Reason referral to local contact agency not made:Find:Pt:^Patient:Nom:CMS Assessment


name: Determination of pressure injury risk:Find:Pt:^Patient:Nom:CMS Assessment


name: W little r super little b Ag:PrThr:Pt:RBC:Ord


name: Treatment preferences under certain health conditions:Find:Pt:^Patient:Nar:Reported


name: Coagulation factor X inhibitor:ACnc:Pt:PPP:Qn:Chromo


name: Erythrocytes.parasite sp infected/100 cells:NFr:Pt:Bld:Qn


name: Erythrocytes.parasite sp infected/100 cells


name: Acute febrile illness global pathogens panel:-:Pt:Bld:-:Non-probe.amp.tar


name: Acute febrile illness global pathogens panel


name: MDS v3.0 - RAI v1.18.11 - Special Treatments, Procedures, and Programs:-:Pt:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Special Treatments, Procedures, and Programs


name: Return to Community:-:Pt:^Patient:-:CMS Assessment


name: Palmitoyl protein thioesterase & Tripeptidyl peptidase I panel:-:Pt:Bld.dot:-


name: Palmitoyl protein thioesterase & Tripeptidyl peptidase I panel


name: Jurisdiction where advance directive is accepted:Loc:Pt:^Patient:Nom


name: Has lack of transportation kept you from medical appointments, meetings, work, or from getting things needed for daily living:Find:Pt:^Patient:Nom:CMS Assessment


name: Borrelia burgdorferi Ab.IgG & IgM with reflex to immunoassay panel:-:Pt:Ser/Plas:-


name: Borrelia burgdorferi Ab.IgG & IgM with reflex to immunoassay panel


name: Bacillus anthracis plasmid pXO1 DNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Bacillus anthracis plasmid pXO2 DNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Bacillus anthracis DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Bacillus anthracis plasmid pXO1 DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Bacillus anthracis plasmid pXO2 DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Yersinia pestis DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Referral has been made to the local contact agency:Find:-:Patient education material:Ord:CMS Assessment


name: Troponin I.cardiac^2H post baseline measurement:MCncDiff:Pt:Ser/Plas:Qn:Calculated


name: inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript:Find:Pt:Bld/Bone mar:Doc:Molgen


name: Lung cancer targeted gene fusion transcript analysis:Find:Pt:Tiss:Doc:Sequencing


name: Lung cancer targeted gene fusion transcript analysis


name: BAP1 gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: BAP1 gene deletion+duplication & full mutation analysis


name: FH gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: FH gene deletion+duplication & full mutation analysis


name: NF1 gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: NF1 gene deletion+duplication & full mutation analysis


name: RET gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: RET gene deletion+duplication & full mutation analysis


name: HBA1 & HBA2 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: GP1BB gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: GP1BA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: GP9 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: PAH gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: ADA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CLCN7 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Copy number variation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Monkeypox virus & Orthopoxvirus.non-variola DNA panel:-:Pt:XXX:-


name: monkeypox virus and non-variola orthopoxvirus DNA panel


name: Monkeypox virus & Orthopoxvirus.non-variola DNA:Prid:Pt:XXX:Nom:Probe.amp.tar


name: Metanephrine, Normetanephrine, 3-Methoxytyramine panel:-:24H:Urine:-


name: Metanephrine, Normetanephrine, 3-Methoxytyramine panel


name: Tapentadol & Nortapentadol panel:-:Pt:Urine:-


name: Phenylalanine & Tyrosine panel:-:Pt:Ser/Plas:-


name: Borrelia afzelii+burgdorferi+garinii Ab.IgG & IgM panel:-:Pt:Ser/Plas:-:IA


name: Amyloid protein:Find:Pt:Tiss:Doc:Congo red stain+LC/MS/MS


name: Anaplasma phagocytophilum & Babesia microti & Ehrlichia chaffeensis Ab.IgG panel:-:Pt:Ser:-


name: C peptide post XXX challenge panel:-:Pt:Ser:-


name: Lymphocyte TCR alpha beta double negative subsets panel:-:Pt:Bld:-


name: Lymphocyte TCR alpha beta double negative subsets panel


name: Blastomyces sp & Blastomyces dermatitidis Ag panel:-:Pt:Urine:-


name: Blastomyces sp & Blastomyces dermatitidis Ag panel


name: Pediatric autoimmune central nervous system disorders evaluation panel:-:Pt:CSF:-


name: Pediatric autoimmune central nervous system disorders evaluation panel


name: Pediatric autoimmune central nervous system disorders evaluation panel:-:Pt:Ser/Plas:-


name: Microorganism level of similarity to reference sample:Score:Pt:Isolate/Specimen:Qn:MS.MALDI-TOF


name: Human coronavirus 229E RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Human coronavirus HKU1 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Human coronavirus NL63 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Human coronavirus OC43 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Influenza virus A H1 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Influenza virus A H3 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Respiratory syncytial virus A RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Respiratory syncytial virus B RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Varicella zoster virus DNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Self-Care - Discharge Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Self-Care - OBRA/Interim Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Mobility - Discharge Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Mobility - OBRA/Interim Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Intentional animal genomic alteration label:-:-:^FDA product label:Nar


name: Intentional animal genomic alteration label


name: CHAMPS pediatric fall risk assessment:Imp:Pt:^Patient:Ord:CHAMPS


name: Soluble urokinase plasminogen activator receptor:MCnc:Pt:Plas:Qn


name: Solitary lung nodule risk of malignancy:Scale:Pt:^Patient:Ord:Calculated.Nodify XL2


name: Solitary lung nodule risk of malignancy:Scale:Pt:^Patient:Ord:Calculated.Nodify CDT


name: Contactin-associated protein 1 Ab.IgG & Neurofascin155 Ab.IgG4 panel:-:Pt:Ser/Plas:-


name: Contactin-associated protein 1 Antibody.immunoglobulin G & Neurofascin155 Antibody.IgG4 panel


name: Contactin-associated protein 1 Ab.IgG:PrThr:Pt:Ser/Plas:Ord:CBA IFA


name: Risk adjustment coding gap report:Find:Pt:{Setting}:Doc:{Role}


name: HBA1+2 gene FIL deletion:PrThr:Pt:Bld:Ord:Molgen


name: HBA1+2 gene THAI deletion:PrThr:Pt:Bld:Ord:Molgen


name: Alpha globin gene deletion panel:-:Pt:Bld:-


name: Adenovirus DNA & Human Metapneumovirus & Rhinovirus RNA panel:-:Pt:Respiratory System Specimen:-:Probe.amp.tar


name: Adenovirus DNA & Human Metapneumovirus & Rhinovirus RNA panel


name: Bacterial susceptibility panel:-:Pt:Bld.pos growth:-:MIC.VOC detection


name: Colony count:NCnc:Pt:XXX:Qn:Culture.standard plate count


name: Salmonella enterica serotype 1,4,[5],12:i:-:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Equine herpesvirus 1 non-neuropathogenic A2254 variant DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Equine herpesvirus 1 neuropathogenic G2254 variant DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Canine parvovirus DNA VP2 gene:PrThr:Pt:Isolate:Ord:Sequencing


name: Canine Parvovirus 2 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Hemorrhagic enteritis virus Ab:Titr:Pt:Ser:SemiQn:IA


name: Hemorrhagic enteritis virus Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Hemorrhagic enteritis virus Ab/Positive control


name: Porcine deltacoronavirus S gene:Seq:Pt:Isolate:Nom:Sequencing


name: Bovine parainfluenza virus 3 Ab.Neut:Titr:Pt:Ser:SemiQn:Neut


name: Porcine epidemic diarrhea virus S1 gene:Prid:Pt:Isolate:Nom:Sequencing


name: Porcine epidemic diarrhea virus Ab.IgG:ACnc:Pt:XXX:Qn:IA


name: Porcine epidemic diarrhea virus S1 gene Ab.IgA:ACnc:Pt:Saliva:Qn:IA


name: Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to RespPRRS:NFr:Pt:Isolate:Qn:Sequencing


name: Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to RespPRRS


name: Fungal 18S rRNA gene:Prid:Pt:XXX:Nom:Sequencing


name: Fungal 18S rRNA gene:Seq:Pt:XXX:Nom:Sequencing


name: Salmonella sp whole genome:Seq:Pt:Isolate:Nom:Sequencing


name: Comprehensive plan of care note:Find:Pt:{Setting}:Doc:Multidisciplinary


name: Bacterial versus viral etiology indicator panel:-:Pt:Ser/Plas:-


name: Bacterial versus viral etiology indicator panel


name: Tumor necrosis factor ligand superfamily member 10:MCnc:Pt:Ser/Plas:Qn


name: Bacterial versus viral infection likelihood:Score:Pt:^Patient:Qn:Calculated


name: Bacterial versus viral infection likelihood


name: Hepatocyte Ag by paraffin 1:Find:Pt:Bld/Tiss:Ord:Immune stain


name: Schmid fall risk assessment:Imp:Pt:^Patient:Ord:Schmid


name: Escherichia coli enteroinvasive DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Sapovirus genogroups I+II+IV RNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Sapovirus genogroup V RNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Thyroglobulin & Thyroglobulin Ab panel:-:Pt:Tiss.FNA:-


name: Bacterial gyrB gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Multisection transthoracic limited for congenital disease:Find:Pt:Chest>Heart:Doc:US


name: Multisection transthoracic limited for congenital disease


name: Multisection transthoracic for congenital disease:Find:Pt:Chest>Heart:Doc:US


name: Multisection transthoracic for congenital disease


name: Views for protein-losing enteropathy^W Tc-99m HSA IV:Find:Pt:Abdomen+Pelvis>Gastrointestinal tract:Doc:NM


name: Borrelia burgdorferi Ab.IgG bands:Num:Pt:CSF:Qn:IB


name: Borrelia burgdorferi Ab.IgM bands:Num:Pt:CSF:Qn:IB


name: MDS v3.0 - RAI v1.17.1, 1.17.2 - Special treatments, procedures, and programs


name: MDS v3.0 - RAI v1.14.1 - Participation in assessment and goal setting


name: How much of the time has pain made it hard for you to sleep at night


name: How often have you limited your day-to-day activities because of pain


name: How often have you limited your participation in rehabilitation therapy sessions due to pain over


name: Troponin I.cardiac^2H post baseline measurement


name: 17-Hydroxypregnenolone^1H post dose corticotropin


name: 17-Hydroxypregnenolone^30M post dose corticotropin


name: Views for protein-losing enteropathy^W Tc-99m HSA IV


name: MDS v3.0 - RAI v1.17.1, 1.17.2 - Pain assessment interview during assessment period


name: Borrelia afzelii+burgdorferi+garinii IgG and IgM panel | Serum or Plasma | Microbiology


name: PRRSV RespPRRS Hmlgy | Isolate | Microbiology


name: Anaplasma phagocytophilum, Babesia microti and Ehrlichia chaffeensis IgG panel | Serum | Microbiology Panels


name: Blastomyces sp & Blastomyces dermatitidis Ag panel | Urine | Microbiology Panels


name: Amoxicillin+Clavulanate | Positive blood culture | Antibiotic susceptibilities


name: Ampicillin+Sulbactam | Positive blood culture | Antibiotic susceptibilities


name: cefTAZidime+Avibactam | Positive blood culture | Antibiotic susceptibilities


name: Ceftolozane+Tazobactam | Positive blood culture | Antibiotic susceptibilities


name: Meropenem+Vaborbactam | Positive blood culture | Antibiotic susceptibilities


name: Piperacillin+Tazobactam | Positive blood culture | Antibiotic susceptibilities


name: Trimethoprim+Sulfamethoxazole | Positive blood culture | Antibiotic susceptibilities


name: Bacterial susceptibility panel | Positive blood culture | Antibiotic Susceptibility Panels


name: 3-Methoxytyramine.free/Creatinine | Serum or Plasma | Chemistry - non-challenge


name: Metanephrine.free/Creatinine | Serum or Plasma | Chemistry - non-challenge


name: Electrolytes panel | Blood venous | Chemistry Panels


name: Gas and electrolytes panel | Blood venous | Chemistry Panels


name: Phenylalanine and Tyrosine panel | Serum or Plasma | Chemistry Panels


name: Thyroglobulin & Thyroglobulin Ab panel | Tissue FNA | Chemistry Panels


name: Glucose post arginine stimulation panel | Serum or Plasma | Challenge Bank Panels


name: Speciociliatine | Umbilical cord tissue | Drug toxicology


name: Dupilumab | Serum or Plasma | Drug toxicology


name: Metanephrine, Normetanephrine, 3-Methoxytyramine panel | Urine | Drug and Toxicology Panels


name: Tapentadol and Nortapentadol panel | Urine | Drug and Toxicology Panels


name: Thrombin generation test | Platelet poor plasma | Coagulation


name: Blood group antigens panel | Father | Blood Bank Panels


name: Blood group antigens panel | Father | Red Blood Cells | Blood Bank Panels


name: CD20 cell expression evaluation | XXX | Cell markers


name: CD49d cell expression evaluation | XXX | Cell markers


name: CD52 cell expression evaluation | XXX | Cell markers


name: Leukemia and lymphoma immunophenotyping | XXX | Cell markers


name: Lymphocyte T-cell and B-cell and Natural killer subsets panel | Cerebral spinal fluid | Cellmarker Panels


name: Lymphocyte TCR alpha beta double negative subsets panel | Blood | Cellmarker Panels


name: Mitochondria whole genome analysis | Blood or Tissue | Molecular pathology


name: Preimplantation multigene analysis | Embryo | Molecular pathology


name: Lung cancer targeted gene fusion transcript analysis | Tissue and Smears | Molecular pathology


name: NAT2 gene product metabolic activity interpretation | Blood or Tissue | Pharmacogenomics


name: Copy number variation analysis | Blood or Tissue | Molecular pathology


name: Alpha globin gene deletion panel | Blood | Molecular Pathology Panels


name: Inflammatory cell infiltrate | Colorectal cancer specimen | Pathology


name: Depth of invasion beyond muscularis propria | Colorectal cancer specimen | Pathology


name: Mesocolic excision plane | Colorectal cancer specimen | Pathology


name: Sphincter excision plane | Colorectal cancer specimen | Pathology


name: Pathology report additional specified observation | Specimen | Pathology


name: Pathologic casts | Urine sediment | Urinalysis


name: Consultation note | Urgent care center | Document ontology


name: History and physical note | Urgent care center | Document ontology


name: Admission evaluation note | Telehealth | Document ontology


name: Progress note | Urgent care center | Document ontology


name: Discharge summary note | Ambulance | Document ontology


name: Appointment reminder | {Setting} | Document ontology


name: Organ AndOr tissue donation consent | {Setting} | Document ontology


name: Cardiac output | Heart.ventricle Right | Specific hemodynamics


name: Application of transcutaneous electric nerve stimulator


name: Discharge to another facility/institution


name: Anticoagulant (e.g., warfarin, heparin, or low-molecular weight heparin)


name: 17-Hydroxyprogesterone^1H post dose corticotropin|Pt|Ser/Plas


name: 17-Hydroxyprogesterone^30M post dose corticotropin|Pt|Ser/Plas


name: Easy Touch HealthPro Glucose Test Strips


name: Kindersprout Organic Plant Protein Kids Nutrition Shake (Chocolate)


name: Kindersprout Organic Plant Protein Kids Nutrition Shake (Vanilla)


name: Nutricia KetoCal 4:1 LQ Enteral Suspension (Chocolate)


name: ORA-Blend SF Sugar-Free Flavored Suspension Vehicle


name: PKU GOLIKE Medical Food Chewable Bar (Tropical)


name: PKU GOLIKE PLUS 4-16 Granules for Solution


name: PanOxyl AM Oil Control Moisturizer with SPF 30 Mineral Sunscreen


name: SmartNeb Suitable For All Ages Compressor Nebulizer System


name: Sterile Water For Injection Diluent for injection


name: Alex Adjustable Travel Folding Cane Butterfly


name: Alex Derby Handle Wood Cane - Black Stain


name: Alex Derby Handle Wood Cane - Brown Stain


name: Alex Ladies' Fritz Handle Wood Cane - Black


name: Alex Ladies' Fritz Wood Cane- Brown Stain


name: Alex Men's Derby Handle Wood Cane - Natural


name: Alex Men's Derby Handle Wood Cane - Rosewood


name: Alex Men's Fritz Handle Wood Cane Brown Stain


name: Alex Men's Fritz Handle Wood Cane-Black Stain


name: Alex Offset Aluminum Cane- Summer Garden


name: Alex Offset Handle Aluminum Cane - Black


name: Alex Offset Handle Aluminum Cane - Celestial


name: Alex Offset Handle Aluminum Cane- Butterfly


name: Alex Offset Handle Aluminum Cane- Paisley


name: Alex Offset Handle Aluminum Cane- Pink Floral


name: Alex Offset Handle Aluminum Cane-Blue Peacock


name: Alex Slim Line Handle Folding Cane- Celectial


name: Alex Straight Adjustable Cane - Canterbury


name: Alex Straight Adjustable Cane - Matte Bronze


name: Alex Straight Adjustable Cane - US Marine


name: Alex Straight Adjustable Cane- Matte Black


name: Alex Travel Folding Cane Slim Handle - Black


name: Alfamino Junior Pediatric Formula Vanilla


name: Aussie 3 Minute Miracle Moist Conditioner


name: Blue Lizard Kids Mineral Sunscreen SPF 50+


name: Burt's Bees Clarifying Facial Towelettes


name: Burt's Bees Refreshing Facial Towelettes


name: Cara Ice Bag 11 Inch Diameter Cold Therapy


name: Freedom Clear Medium Male External Catheter


name: Gillette Cool Wave Antiperspirant Deodorant


name: Gillette Mach3 Sensitive Disposable Razors


name: Gillette Power Rush Antiperspirant Protection


name: Gillette Venus Comfort Glide Disposable Razor


name: Hawaiian Tropic Sheer Touch Sunscreen SPF 70


name: Hawaiian Tropic Sunscreen Clear Spray SPF 70


name: Jobst For Men Ambition Size 1 Socks Navy


name: Jobst For Men M Size Compression Socks Black


name: Jobst Medical Compression Size 2 Navy Socks


name: Jobst SoSoft White Large Compression Socks


name: Jobst SoSoft White Medium Compression Socks


name: John Frieda Frizz Ease Dream Curls Spray


name: John Frieda Frizz Ease Firm Hold Hairspray


name: Kindersprout Plant Protein Chocolate Shake


name: Kindersprout Plant Protein Kids Vanilla Shake


name: Mueller 4-Way Stretch Knee Support SM/MD


name: Mueller Elastic Knee Stabilizer Small/Medium


name: Mueller Sport Care Reusable Cold-Hot Pack


name: Mueller Sports Medicine Compression Glove


name: Mueller Sports Medicine Hybrid Ankle Support


name: Neutrogena Beach Defense Sunscreen SPF 50


name: Neutrogena Ultra Sheer Body Mist Spray SPF 70


name: Olly Collagen Gummy Rings, Peach Bellini


name: Gillette Cool Wave Antiperspirant Protection


name: Cleanser Topical application Soap [NEUTROGENA DEEP CLEAN]


name: Medical Food Oral Gel/Jelly [GELATEIN MCT]


name: Medical Food Oral Capsule [NEUROPHX DPN]


name: Medical Food Oral Liquid [PROSOURCE TF20]


name: L-Methylfolate/Methylcobalamin/Pyridoxal Phosphate 3 MG-2 MG-35 MG Oral Tablet


name: Collagen, Axolotl Topical application Dressing


name: GUAIFENESIN 1 kg in 1 kg NOT APPLICABLE POWDER


name: AVOBENZONE 2.9 g in 100 mL / HOMOSALATE 9.8 g in 100 mL / OCTISALATE 4.9 g in 100 mL / OCTOCRYLENE 9.5 g in 100 mL TOPICAL SPRAY [Sun Plus Skincare SPF 50 Sport Sunscreen]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OXYBENZONE 60 mg in 1 g TOPICAL SPRAY [TopCare Everyday Sport Continuous Broad Spectrum SPF 70]


name: HOMOSALATE 10 g in 100 mL / OXYBENZONE 5 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 5 g in 100 mL / AVOBENZONE 2 g in 100 mL TOPICAL LOTION [SUN SHIELD SUNSCREEN SPF 30]


name: HOMOSALATE 80 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [CVS Health SPF 30 Ultra Sheer]


name: HOMOSALATE 80 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [Harmon Face Values Ultra Light Dry to the Touch Sunscreen SPF 30]


name: HOMOSALATE 80 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [Wegmans Sheer Broad Spectrum SPF 30 Dry Touch Sunscreen]


name: HOMOSALATE 80 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL / OXYBENZONE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [CVS Health SPF 30 Ultra Sheer]


name: OCTINOXATE 7 g in 100 mL / ZINC OXIDE 6 g in 100 mL TOPICAL LOTION [Protect Daily Moisturizer Sunscreen Broad Spectrum SPF 25]


name: OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Walgreens SPF 50 Hydrating]


name: OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Wegmans Kids and Sport Broad Spectrum SPF 50 Sunscreen]


name: TITANIUM DIOXIDE 7.75 g in 100 mL / ZINC OXIDE 10 g in 100 mL TOPICAL CREAM [Ti Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF30]


name: Zinc Oxide 160 mg in 1 g TOPICAL CREAM [Emme Diane Pure Protection Tinted Antioxidant Sunscreen]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 14.39 g in 100 mL TOPICAL LOTION [Hand Saver]


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 8.75 g in 50 g TOPICAL GEL [Face Saver Gel]


name: AVOBENZONE 2 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTINOXATE 5 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL SPRAY [HEALTHY GLOW SUNLESS TAN BROAD SPECTRUM SUNSCREEN SPF 40]


name: .ALPHA.-HEXYLCINNAMALDEHYDE 0.00244785 g in 100 mL / LIMONENE, (+)- 0.001156785 g in 100 mL TOPICAL CREAM [Puritying Skin BalanceCream]


name: .BETA.-CITRONELLOL, (R)- 0.00271206 g in 100 mL TOPICAL LIQUID [Hydrating extra concentrate serum]


name: .BETA.-CITRONELLOL, (R)- 0.0090402 g in 100 mL TOPICAL LIQUID [Hydrating Treatment Toner]


name: .BETA.-CITRONELLOL, (R)- 0.0090408 g in 100 mL / GERANIOL 0.003019675 g in 100 mL TOPICAL OIL [Hydrating luxurious roseoil]


name: .BETA.-CITRONELLOL, (R)- 0.0090408 g in 100 mL TOPICAL LIQUID [Purifying relief soothing gel essence]


name: ADENOSINE 0.04 g in 100 mL / NIACINAMIDE 2 g in 100 mL TOPICAL LIQUID [Hydrating all in one concentrate treatment mask]


name: LIMONENE, (+)- 0.00185573 g in 100 mL TOPICAL LIQUID [Purifying Balance Soothing Peeling Pad]


name: LIMONENE, (+)- 0.00371146 g in 100 g / LINALOOL, (+/-)- 0.00109203 g in 100 g TOPICAL LIQUID [Purifying centella soothing mask]


name: STARFIRE RED PRISTELLA TRANSGENIC WHOLE (RPM2022 RDNA CONSTRUCT) 1 [Amb'a'1'U] in 1 [Amb'a'1'U] NOT APPLICABLE NOT APPLICABLE [StarFire Red Pristella]


name: ZINC OXIDE 22 g in 100 mL TOPICAL CREAM [Sun Plus Skincare SPF 50 Mineral Bronzing Body Butter Coconut]


name: ATIPAMEZOLE 1 kg in 1 kg NOT APPLICABLE POWDER


name: TITANIUM DIOXIDE 12 mg in 1 g / ZINC OXIDE 4.2 mg in 1 g TOPICAL POWDER [Mineral Wear Loose Powder]


name: TITANIUM DIOXIDE 15 g in 100 g / ZINC OXIDE 10 g in 100 g TOPICAL POWDER [Super BB All in 1 Beauty Balm Powder]


name: TITANIUM DIOXIDE 57.6 mg in 1 mL / ZINC OXIDE 29.4 mg in 1 mL TOPICAL CREAM [Super BB All in 1 Beauty Balm Cream]


name: ZINC OXIDE 20 g in 100 mL TOPICAL LOTION [Bliss Block Star Sheer Liquid Daily Sunscreen SPF 50 SPF-50]


name: CAPSAICIN 0.19 g in 100 g TOPICAL CLOTH [Nufabrx Lower Leg Sleeve M/L]


name: CAPSAICIN 0.2 g in 100 g TOPICAL CLOTH [Nufabrx Arm Sleeve]


name: LINALOOL, (+/-)- 0.0028142856 g in 100 g / .BETA.-CITRONELLOL, (R)- 0.03018988 g in 100 g / GERANIOL 0.007430248 g in 100 g TOPICAL POWDER [Protecting may morning cushion 21 (refill)]


name: Maropitant Citrate 1 kg in 1 kg NOT APPLICABLE POWDER


name: NIACINAMIDE 2 g in 100 mL / ADENOSINE 0.04 g in 100 mL TOPICAL CREAM [Protecting base suncream]


name: NIACINAMIDE 2 g in 100 mL / ADENOSINE 0.04 g in 100 mL TOPICAL CREAM [Protecting tone up and glow B.B]


name: CAPSAICIN 0.12 g in 100 g TOPICAL CLOTH [Nufabrx Ankle Sleeve]


name: CAPSAICIN 0.15 g in 100 g TOPICAL CLOTH [Nufabrx Knee Sleeve]


name: TITANIUM DIOXIDE 65 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL LOTION [My Day Screen Tinted Body Screen Mini Medium Bronze]


name: CAPSAICIN 0.12 g in 100 g TOPICAL CLOTH [Nufabrx Foot/Ankle Sleeve]


name: CAPSAICIN 0.23 g in 100 g TOPICAL CLOTH [Nufabrx Wrist Sleeve]


name: CHLOROXYLENOL 3.09 mg in 1 mL TOPICAL LIQUID [American Raven Ultra ANTIBACTERIAL DishSoap]


name: RICE GERM 0.0000001 g in 100 mL TOPICAL LIQUID [Claritying rice rebalancing cleansing water]


name: ZINC OXIDE 19.6 g in 100 mL TOPICAL LOTION [Oars and Alps SPF 50 Mineral]


name: AVOBENZONE 2.9 g in 100 mL / HOMOSALATE 9.8 g in 100 mL / OCTISALATE 4.9 g in 100 mL / OCTOCRYLENE 9.5 g in 100 mL TOPICAL SPRAY [Oars and Alps SPF 70 Hydrating Antioxidant Sunscreen]


name: ZINC OXIDE 15.7 g in 100 mL / TITANIUM DIOXIDE 3.4 g in 100 mL TOPICAL SPRAY [Oars and Alps SPF 50 100% Mineral Antioxidant Sunscreen]


name: HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL LOTION [Coppertone Complete Sunscreen SPF 45]


name: BENZETHONIUM CHLORIDE 0.06 mg in 29.6 mL / DYCLONINE HYDROCHLORIDE 0.23 mg in 29.6 mL TOPICAL LIQUID [Liquid Bandage]


name: RICE GERM 0.00055 g in 100 mL TOPICAL LIQUID [Claritying rice gently off lip and eye remover]


name: LEDIKITE 0.01 g in 100 g TOPICAL STICK [Solcure Water Balm]


name: LINALOOL, (+/-)- 0.0123856248 g in 100 mL / .BETA.-CITRONELLOL, (R)- 0.0072288108 g in 100 mL / GERANIOL 0.003659868 g in 100 mL / LIMONENE, (+/-)- 0.0330317226 g in 100 mL TOPICAL CREAM [Intensive treatment bodycream for mommy to be and all skin]


name: Johnson and Johnson First Aid Travel Ready 80 CT KIT


name: Johnson and Johnson First Aid All Purpose 160 CT KIT


name: OCTISALATE 4.9 g in 100 mL / OCTOCRYLENE 9.5 g in 100 mL / AVOBENZONE 2.8 g in 100 mL TOPICAL LIQUID [Sea and C Glow Bronzing Body Oil SPF 20]


name: ZINC OXIDE 24 g in 100 g TOPICAL LOTION [Eucerin Sensitive Mineral Face Sunscreen SPF 35]


name: APPLE FRUIT OIL 58.69 g in 100 mL TOPICAL GEL [Boosting apple soothing wash off]


name: ARGAN OIL 0.001 g in 100 mL TOPICAL LIQUID [Hair care conditioning Boosting essence]


name: MINOCYCLINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: NIACINAMIDE 2 g in 100 mL / ADENOSINE 0.04 g in 100 mL TOPICAL LIQUID [Hydrating all in one glow concentrate ampoule]


name: ZINC OXIDE 24.05 mg in 100 mg TOPICAL CREAM [Cream]


name: ZINC OXIDE 6 g in 100 mL / OCTOCRYLENE 7.6 g in 100 mL TOPICAL SPRAY [Mattify and Protect Daily Priming SPF 35]


name: CAPSAICIN 0.18 g in 100 g TOPICAL CLOTH [Nufabrx Knee Sleeve]


name: AVOBENZONE 3 g in 100 g / OCTOCRYLENE 9 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [Coppertone Every Tone Sunscreen SPF 50]


name: HOMOSALATE 0.1015 g in 1 g / OCTINOXATE 0.077 g in 1 g / ZINC OXIDE 0.077 g in 1 g TOPICAL CREAM


name: HOMOSALATE 9.8 g in 100 mL / OCTISALATE 4.9 g in 100 mL / OCTOCRYLENE 9.5 g in 100 mL / AVOBENZONE 2.9 g in 100 mL TOPICAL SPRAY [Set and Protect Matte Sheer Setting Mist SPF 45]


name: OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g / AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g TOPICAL LOTION [Coppertone Oil Free and Shine Control Face Sunscreen SPF 45]


name: OCTISALATE 5 mg in 100 mg / HOMOSALATE 10 mg in 100 mg / AVOBENZONE 3 mg in 100 mg / OCTOCRYLENE 10 mg in 100 mg TOPICAL GEL [Sunscreen]


name: ZINC OXIDE 12 g in 100 mL TOPICAL LOTION [GUARDIAN ANGEL SUPER PEPTIDE SUNSCREEN MILK SPF-50]


name: ZINC OXIDE 24.08 g in 100 g SUPRACHOROIDAL LOTION [Coppertone Kids Roll-On Sunscreen SPF 50]


name: LIMONENE, (+)- 0.005016382 g in 100 mL TOPICAL GEL [Purifying S.O.S spotgel]


name: ZINC OXIDE 19 g in 100 g TOPICAL CREAM [Wonderscreen Tinted Broad Spectrum SPF 30]


name: ADENOSINE 0.08 g in 100 g / NIACINAMIDE 4 g in 100 g TOPICAL LIQUID [Solcure 2 be1 Magic Pack]


name: AVOBENZONE 100 mg in 4 g / OCTINOXATE 196 mg in 4 g / OCTOCRYLENE 120 mg in 4 g TOPICAL EMULSION [cle de peau BEAUTE PROTECTIVE LIP TREATMENT SPF 25]


name: METFORMIN HYDROCHLORIDE 500 mg in 1 kg NOT APPLICABLE POWDER


name: METFORMIN HYDROCHLORIDE 750 mg in 1 kg NOT APPLICABLE POWDER


name: METFORMIN HYDROCHLORIDE 97 mg in 100 mg POWDER


name: POTASSIUM CHLORIDE 50 kg in 50 kg NOT APPLICABLE POWDER


name: OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Big Lots Soundbody SPF 50 Baby Sunscreen]


name: OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [CVS Health Sport SPF 50 Sunscreen]


name: OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Family Dollar Tropic Sun SPF 50 Baby Sunscreen]


name: ZINC OXIDE 15.2 g in 100 mL TOPICAL AEROSOL, SPRAY [Chantecaille SeaScreen 30 Mineral Broad-Spectrum Sunscreen Mist SPF 30]


name: ZINC OXIDE 25 kg in 100 kg TOPICAL CREAM [SParms Organic Kids Sunscreen]


name: ZINC OXIDE 180 mg in 1 mL TOPICAL SOLUTION [SEAWEED BATH CO. Super Sheer Face Serum SPF-50]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Secret Delicate Rose Invisible]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 5 g in 100 mL / OCTISALATE 3 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [Premium Moisturizing Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Big Lots Soundbody SPF 50 Ultra Shield Sunscreen]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [CVS Health SPF 50 Clear]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Equaline Ultra Protection Continuous Sunscreen SPF 50]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [H-E-B SOLUTIONS SUNSCREEN COCONUT SPF 50 CONTINUOUS]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Market Basket Continuous Sunscreen SPF 50]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Wegmans Sport and Kids Clear Continuous Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Equate Sunscreen for All Skin Tones SPF 50]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [TopCare Everyday Ultra Protection Sun SPF 30]


name: HOMOSALATE 60 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OCTOCRYLENE 30 mg in 1 mL / AVOBENZONE 25 mg in 1 mL TOPICAL LOTION [CVS Health SPF 30 Breakout Free Face]


name: OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 5 g in 100 g / ZINC OXIDE 4.93 g in 100 g / HOMOSALATE 6.25 g in 100 g TOPICAL CREAM [TRUE COMPLEXION TINTED MOISTURIZER]


name: OCTISALATE 4.9 g in 100 mL / HOMOSALATE 9.8 g in 100 mL / OCTOCRYLENE 9.5 g in 100 mL / AVOBENZONE 2.9 g in 100 mL TOPICAL LIQUID [Sea and C Sheer Face Serum]


name: OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL SPRAY [CVS Health SPF 30 Clear]


name: OCTOCRYLENE 35 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / AVOBENZONE 27 mg in 1 mL TOPICAL LOTION [CVS Health SPF 30 Beach Guard]


name: OCTOCRYLENE 35 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / AVOBENZONE 27 mg in 1 mL TOPICAL LOTION [Walgreens SPF 30 Hydrating]


name: PETROLATUM 1.147 g in 3.7 g / OCTINOXATE 0.2775 g in 3.7 g / OXYBENZONE 0.111 g in 3.7 g / AVOBENZONE 0.074 g in 3.7 g TOPICAL LIPSTICK [ELIZABETH ARDEN EIGHT HR PROTECTANT CLEAR]


name: TITANIUM DIOXIDE 3.71 g in 100 mL / ZINC OXIDE 2.71 g in 100 mL TOPICAL CREAM [spf 30 mineral Sunscreen]


name: Zinc Oxide 126 mg in 1 mL TOPICAL LOTION [SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen 13 La Cienega]


name: Zinc Oxide 126 mg in 1 mL TOPICAL LOTION [SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen 18 Montana]


name: Zinc Oxide 126 mg in 1 mL TOPICAL LOTION [SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen 38 Pomona]


name: Butylscopolamine Bromide 1 kg in 1 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 20.8 g in 100 mL TOPICAL LIQUID [Kind Tint SPF 30]


name: ZINC OXIDE 20.8 g in 100 mL TOPICAL SPRAY [Glow Baby Super Lit SPF 30]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Secret Outlast Completely Clean Invisible Completely Clean]


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 20 g in 100 g TOPICAL CREAM [Gillette Clinical Soft Arctic Ice]


name: AVOBENZONE 0.1175 g in 4.25 g / OCTINOXATE 0.282 g in 4.25 g / OXYBENZONE 0.141 g in 4.25 g TOPICAL STICK [Sun Shades Lip Balm Cranberry Tangerine]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [Premium Moisturizing Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 15 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [Premium Moisturizing Sunscreen Broad Spectrum SPF 70]


name: HOMOSALATE 150 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL LIPSTICK [Replenix Lip Therapy homosalate]


name: OCTOCRYLENE 10 g in 100 mL / AVOBENZONE 2 g in 100 mL / HOMOSALATE 5 g in 100 mL / OCTISALATE 2 g in 100 mL TOPICAL LOTION [Premium Moisturizing Sunscreen Broad Spectrum SPF 15]


name: TITANIUM DIOXIDE 172.9 mg in 1 g / ZINC OXIDE 200 mg in 1 g TOPICAL POWDER [Derma E Mineral sunscreen Mineral]


name: TITANIUM DIOXIDE 30 mg in 1 mL / ZINC OXIDE 150 mg in 1 mL TOPICAL LOTION [Fruit of the Earth Sun Town City Baby and Kids Mineral SPF 50 Sunscreen]


name: TITANIUM DIOXIDE 35 mg in 1 g / ZINC OXIDE 72.5 mg in 1 g TOPICAL SPRAY [Fruit of the Earth Sun Town City Baby and Kids Mineral SPF 50 Sunscreen]


name: TITANIUM DIOXIDE 70 mg in 1 g / ZINC OXIDE 47 mg in 1 g TOPICAL STICK [Fruit of the Earth Sun Town City Stick Mineral SPF 50]


name: ASCORBIC ACID 81 mg in 11.3 g / CHOLECALCIFEROL 10 ug in 11.3 g / .ALPHA.-TOCOPHEROL 7 mg in 11.3 g / NIACINAMIDE 5 mg in 11.3 g / BIOTIN 16 ug in 11.3 g / ZINC SULFATE MONOHYDRATE 3 mg in 11.3 g / SELENIUM 16 ug in 11.3 g / MARINE COLLAGEN, SOLUBLE 1625 mg in 11.3 g / PSYLLIUM HUSK 4000 mg in 11.3 g / ORANGE JUICE 4000 mg in 11.3 g / CURCUMIN 25 mg in 11.3 g / HYALURONIC ACID 16 mg in 11.3 g / ALOE VERA LEAF 38 mg in 11.3 g / OPHIOCORDYCEPS SINENSIS 38 mg in 11.3 g / ELASTIN BOVINE 4 mg in 11.3 g / SOYBEAN 38 mg in 11.3 g / RICE BRAN 38 mg in 11.3 g ORAL POWDER [JBA Collagen-BETHIN Mocktail with PSYLLIUM FIBER CurCousin]


name: ZINC OXIDE 20 g in 100 mL TOPICAL LOTION [SOLARA SUNCARE - FORTUNE TELLER SPF-30]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Secret Invigorating Citrus Invisible]


name: OCTISALATE 4.9 g in 100 mL / ZINC OXIDE 7 g in 100 mL / OCTOCRYLENE 7.6 g in 100 mL TOPICAL SPRAY [Sun Plus Skincare SPF 30 Sea and C Sheer Sunscreen]


name: OCTOCRYLENE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL / HOMOSALATE 15 g in 100 mL TOPICAL LOTION [Vegan Collagen Every Day SPF 30]


name: TITANIUM DIOXIDE 30 mg in 1 mL / ZINC OXIDE 100 mg in 1 mL TOPICAL LOTION [Fruit of the Earth Sun Town City Mineral SPF 30 Sunscreen]


name: Titanium Dioxide 80 mg in 1 g / Zinc Oxide 38 mg in 1 g TOPICAL CREAM [BHSkin Sheer Tinted Zinc and Titanium SPF 40]


name: Titanium Dioxide 80 mg in 1 g / Zinc Oxide 38 mg in 1 g TOPICAL CREAM [Priia Tinted Mineral Sunscreen and Primer]


name: ZINC OXIDE 150 mg in 1 g TOPICAL SPRAY [Fruit of the Earth Sun Town City Mineral SPF 30 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Cabana Beach Club with Blood Orange and Essential Oils SPF 50 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Cabana Beach Club with Manuka Honey and Essential Oils SPF 50 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Cabana Beach Club with Mentha and Essential Oils SPF 50 Sunscreen]


name: HOMOSALATE 40 mg in 1 mL / AVOBENZONE 5 mg in 1 mL TOPICAL SPRAY [Equate Sunscreen Tanning Oil With Coconut Oil SPF 6]


name: OCTINOXATE 7 g in 100 mL / ZINC OXIDE 6 g in 100 mL TOPICAL LOTION [FOR THE WIN Sunscreen Broad Spectrum SPF 25]


name: OCTINOXATE 7 g in 100 mL / ZINC OXIDE 6 g in 100 mL TOPICAL LOTION [SPF BFF Sunscreen Broad Spectrum SPF 25]


name: OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 7 g in 100 g / HOMOSALATE 8 g in 100 g / AVOBENZONE 2 g in 100 g TOPICAL AEROSOL, SPRAY [Coppertone Limited Edition Sunscreen SPF 30]


name: AVOBENZONE 3 g in 30 mL / OCTISALATE 5 g in 30 mL TOPICAL LOTION [TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30]


name: SALICYLIC ACID 11.4 g in 100 mL TOPICAL CREAM [Ultra CC Radiant Foundation Broad Spectrum SPF 17 Warm-Medium]


name: ZINC OXIDE 11.4 g in 100 mL TOPICAL CREAM [Ultra CC Radiant Foundation Broad Spectrum SPF 17 Cool-Deep]


name: ZINC OXIDE 11.4 g in 100 mL TOPICAL CREAM [Ultra CC Radiant Foundation Broad Spectrum SPF 17 Light-Warm]


name: ZINC OXIDE 11.4 g in 100 mL TOPICAL CREAM [Ultra CC Radiant Foundation Broad Spectrum SPF 17 Natural-Medium]


name: ZINC OXIDE 11.4 g in 100 mL TOPICAL CREAM [Ultra CC Radiant Foundation Broad Spectrum SPF 17 Neutral-Fair]


name: ZINC OXIDE 11.4 g in 100 mL TOPICAL CREAM [Ultra CC Radiant Foundation Broad Spectrum SPF 17 Warm-Tan]


name: ZINC OXIDE 5.0076 g in 100 mL / TITANIUM DIOXIDE 6 g in 100 mL TOPICAL LIQUID [TULA Ultimate Sun Serum PentaPeptide Sunscreen Broad Spectrum SPF 50]


name: TITANIUM DIOXIDE 7.75 g in 100 mL / ZINC OXIDE 10 g in 100 mL TOPICAL CREAM [Tinted Sunscreen AM -Broad Spectrum SPF 30]


name: ZINC OXIDE 12 g in 100 g TOPICAL LOTION [Saranghae Lets Get Physical Sheer UV Defense Sunscreen Broad Spectrum SPF 50]


name: TULA Skincare Clear Skin Starters Travel-size Acne and Blemish Fighting Kit KIT


name: AVOBENZONE 1.031 g in 50 mL / OCTINOXATE 2.52595 g in 50 mL / OCTOCRYLENE 2.5775 g in 50 mL / OXYBENZONE 1.031 g in 50 mL TOPICAL CREAM [cle de peau BEAUTE PROTECTIVE FORTIFYING n]


name: AVOBENZONE 1.2167 g in 50 mL / HOMOSALATE 5.29 g in 50 mL / OCTISALATE 2.645 g in 50 mL / OCTOCRYLENE 2.645 g in 50 mL TOPICAL CREAM [cle de peau BEAUTE UV PROTECTIVE N]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [Sun Bum Face 50 Premium Sunscreen SPF 50]